Those of us who have had a radical prostatectomy and then have our PSA return are experiencing what the industry calls a biochemical recurrence. As with all things prostate cancer, there is a lack of agreement on how best to clinically respond to our situation. In the May issue of the Journal of Clinical Oncology, [...]
Prostate Cancer advocates continue to press the FDA to approve Provenge by staging marches in Washington and Chicago as well as continuing to add their names to Malecare's Action Letter. The advocacy has even caught the attention of the major news services, which have been carrying many stories about the efforts of the prostate community. [...]
Those of us who have life insurance policies, either group or individual, may not be required to continue to pay the premiums! Many policies contain a waiver of premiums in case of disability. If you are disabiled, check your policy for a section entitled "waiver of premium" or a similar category to verify that this [...]
Oncology professionals, PC doctors, nurses, physical therapists and administrators, take pride for those they cure or for those of us for whom they are able to provide a progression-free survival. Sometimes it isn't about only that. Sometimes it’s also about one more birthday, a graduation, making it to that wedding or to be able to [...]
Dollars -- public and private -- spent on one area, have, of course, been diverted FROM another. I join you in desperately wishing to see greater support for research and treatment of prostate cancer, but having lost my dad to colon cancer, my secretary and my younger sister to breast cancer, my kids' godfather to [...]